RSK3: A regulator of pathological cardiac remodeling

IUBMB Life

Volumn 67, Issue 5, 2015, Pages 331-337

  Martinez, Eliana C ^a   Passariello, Catherine L ^a   Li, Jinliang ^a   Matheson, Christopher J ^b   Dodge Kafka, Kimberly ^c   Reigan, Philip ^b   Kapiloff, Michael S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

heart; hypertrophy; mAKAP; remodeling; ribosomal S6 kinase; scaffold; signal transduction

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE INHIBITOR; S6 KINASE; KCNN3 PROTEIN, RAT; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ENZYME ACTIVITY; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PATHOGENESIS; PATHOLOGY; REVIEW; ANIMAL; CARDIAC MUSCLE CELL; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; HUMANS; MYOCYTES, CARDIAC; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; STRESS, PHYSIOLOGICAL;

EID: 84930208003     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1383     Document Type: Review

References (79)

1. Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., et al.,; and the American Heart Association Statistics Committee and the Stroke Statistics Subcommittee. (2014) Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129, e28-e292.
2. Braunwald, E., (2013) Heart failure. JACC Heart Fail. 1, 1-20.
3. Loffredo, F. S., Nikolova, A. P., Pancoast, J. R., and, Lee, R. T., (2014) Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. Circ. Res. 115, 97-107.
4. Sharma, K., and, Kass, D. A., (2014) Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ. Res. 115, 79-96.
5. Finn, S. G., Dickens, M., and, Fuller, S. J., (2001) c-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes. Biochem. J. 358, 489-495.
6. Sundaresan, N. R., Gupta, M., Kim, G., Rajamohan, S. B., Isbatan, A., et al., (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 119, 2758-2771.
7. Frey, N., and, Olson, E. N., (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65, 45-79.
8. The CONSENSUS Trial Study Group. (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N. Engl. J. Med. 316, 1429-1435.
9. Esposito, G., Rapacciuolo, A., Naga Prasad, S. V., Takaoka, H., Thomas, S. A., et al., (2002) Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105, 85-92.
10. Heineke, J., and, Molkentin, J. D., (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7, 589-600.
11. Li, J., Kritzer, M. D., Michel, J. J., Le, A., Thakur, H., et al., (2013) Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy. Circ. Res. 112, 128-139.
12. Passariello, C. L., Gayanilo, M., Kritzer, M. D., Thakur, H., Cozacov, Z., et al., (2013) p90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in α-tropomyosin Glu180Gly transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 305, H1010-H1019.
13. Anjum, R., and, Blenis, J., (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat. Rev. Mol. Cell Biol. 9, 747-758.
14. Romeo, Y., Zhang, X., and, Roux, P. P., (2012) Regulation and function of the RSK family of protein kinases. Biochem. J. 441, 553-569.
15. Hauge, C., and, Frodin, M., (2006) RSK and MSK in MAP kinase signalling. J. Cell Sci. 119, 3021-3023.
16. Leighton, I. A., Dalby, K. N., Caudwell, F. B., Cohen, P. T., and, Cohen, P., (1995) Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett. 375, 289-293.
17. Frodin, M., Jensen, C. J., Merienne, K., and, Gammeltoft, S., (2000) A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J. 19, 2924-2934.
18. Roux, P. P., Richards, S. A., and, Blenis, J., (2003) Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol. Cell. Biol. 23, 4796-4804.
19. Zhao, Y., Bjorbaek, C., Weremowicz, S., Morton, C. C., and, Moller, D. E., (1995) RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol. Cell. Biol. 15, 4353-4363.
20. Doehn, U., Gammeltoft, S., Shen, S. H., and, Jensen, C. J., (2004) p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cdelta. Biochem. J. 382, 425-431.
21. Bignone, P. A., Lee, K. Y., Liu, Y., Emilion, G., Finch, J., et al., (2007) RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene 26, 683-700.
22. Zeniou, M., Ding, T., Trivier, E., and, Hanauer, A., (2002) Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. Hum. Mol. Genet. 11, 2929-2940.
23. Lin, J. X., Spolski, R., and, Leonard, W. J., (2008) Critical role for Rsk2 in T-lymphocyte activation. Blood 111, 525-533.
24. Lara, R., Mauri, F. A., Taylor, H., Derua, R., Shia, A., et al., (2011) An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis. Oncogene 30, 3513-3521.
25. Dufresne, S. D., Bjorbaek, C., El-Haschimi, K., Zhao, Y., Aschenbach, W. G., et al., (2001) Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol. Cell. Biol. 21, 81-87.
26. Facher, J. J., Regier, E. J., Jacobs, G. H., Siwik, E., Delaunoy, J. P., et al., (2004) Cardiomyopathy in Coffin-Lowry syndrome. Am. J. Med. Genet. A 128, 176-178.
27. Sadoshima, J., and, Izumo, S., (1993) Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12, 1681-1692.
28. Yamazaki, T., Tobe, K., Hoh, E., Maemura, K., Kaida, T., et al., (1993) Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J. Biol. Chem. 268, 12069-12076.
29. Sadoshima, J., Qiu, Z., Morgan, J. P., and, Izumo, S., (1995) Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ. Res. 76, 1-15.
30. Baliga, R. R., Pimental, D. R., Zhao, Y. Y., Simmons, W. W., Marchionni, M. A., et al., (1999) NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am. J. Physiol. 277, H2026-H2037.
31. Takeishi, Y., Abe, J., Lee, J. D., Kawakatsu, H., Walsh, R. A., et al., (1999) Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts. Circ. Res. 85, 1164-1172.
32. Kodama, H., Fukuda, K., Pan, J., Sano, M., Takahashi, T., et al., (2000) Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 279, H1635-H1644.
33. Snabaitis, A. K., Muntendorf, A., Wieland, T., and, Avkiran, M., (2005) Regulation of the extracellular signal-regulated kinase pathway in adult myocardium: differential roles of G(q/11), Gi and G(12/13) proteins in signalling by α1-adrenergic, endothelin-1 and thrombin-sensitive protease-activated receptors. Cell. Signal. 17, 655-664.
34. Takimoto, E., and, Kass, D. A., (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49, 241-248.
35. Takeishi, Y., Huang, Q., Abe, J., Che, W., Lee, J. D., et al., (2002) Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc. Res. 53, 131-137.
36. + exchanger-directed protein kinases in the ischemic and ischemic-reperfused rat myocardium. J. Biol. Chem. 276, 16113-16122.
37. Cohen, M. S., Zhang, C., Shokat, K. M., and, Taunton, J., (2005) Structural bioinformatics-based design of selective, irreversible kinase inhibitors. Science 308, 1318-1321.
38. + exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK): effects of the novel and specific RSK inhibitor FMK on responses to α1-adrenergic stimulation. Mol. Pharmacol. 71, 799-806.
39. + exchanger-mediated cardiac ischemia-reperfusion injury. Circulation 113, 2516-2523.
40. Itoh, S., Ding, B., Shishido, T., Lerner-Marmarosh, N., Wang, N., et al., (2006) Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium. Circulation 113, 1787-1798.
41. + channel activity. Circ. Res. 103, 269-278.
42. Li, T., Liu, Z., Hu, X., Ma, K., and, Zhou, C., (2012) Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4. Biochim. Biophys. Acta 1823, 582-592.
43. Itoh, S., Ding, B., Bains, C. P., Wang, N., Takeishi, Y., et al., (2005) Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-β)-mediated cardiac troponin I phosphorylation. J. Biol. Chem. 280, 24135-24142.
44. Cuello, F., Bardswell, S. C., Haworth, R. S., Ehler, E., Sadayappan, S., et al., (2011) Novel role for p90 ribosomal S6 kinase in the regulation of cardiac myofilament phosphorylation. J. Biol. Chem. 286, 5300-5310.
45. Clark, D. E., Errington, T. M., Smith, J. A., Frierson, H. F., Jr,., Weber, M. J., et al., (2005) The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res. 65, 3108-3116.
46. Smith, J. A., Poteet-Smith, C. E., Xu, Y., Errington, T. M., Hecht, S. M., et al., (2005) Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res. 65, 1027-1034.
47. Serra, V., Eichhorn, P. J., Garcia-Garcia, C., Ibrahim, Y. H., Prudkin, L., et al., (2013) RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer. J. Clin. Invest. 123, 2551-2563.
48. Milosevic, N., Kuhnemuth, B., Muhlberg, L., Ripka, S., Griesmann, H., et al., (2013) Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer. Neoplasia 15, 1354-1362.
49. Shimizu, T., Tolcher, A. W., Papadopoulos, K. P., Beeram, M., Rasco, D. W., et al., (2012) The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer. Clin. Cancer Res. 18, 2316-2325.
50. Michel, J. J., Townley, I. K., Dodge-Kafka, K. L., Zhang, F., Kapiloff, M. S., et al., (2005) Spatial restriction of PDK1 activation cascades by anchoring to mAKAPα. Mol. Cell 20, 661-672.
51. Pare, G. C., Easlick, J. L., Mislow, J. M., McNally, E. M., and, Kapiloff, M. S., (2005) Nesprin-1α contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp. Cell Res. 303, 388-399.
52. Scott, J. D., and, Pawson, T., (2009) Cell signaling in space and time: where proteins come together and when they're apart. Science 326, 1220-1224.
53. Negro, A., Dodge-Kafka, K., and, Kapiloff, M. S., (2008) Signalosomes as therapeutic targets. Prog. Pediatr. Cardiol. 25, 51-56.
54. Marx, S. O., Reiken, S., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., et al., (2000) PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365-376.
55. Kapiloff, M. S., Jackson, N., and, Airhart, N., (2001) mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J. Cell Sci. 114, 3167-3176.
56. Dodge-Kafka, K. L., Soughayer, J., Pare, G. C., Carlisle Michel, J. J., Langeberg, L. K., et al., (2005) The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437, 574-578.
57. Wong, W., Goehring, A. S., Kapiloff, M. S., Langeberg, L. K., and, Scott, J. D., (2008) mAKAP compartmentalizes oxygen-dependent control of HIF-1α. Sci. Signal. 1, ra18.
58. Kapiloff, M. S., Piggott, L. A., Sadana, R., Li, J., Heredia, L. A., et al., (2009) An adenylyl cyclase-mAKAPβ signaling complex regulates cAMP levels in cardiac myocytes. J. Biol. Chem. 284, 23540-23546.
59. Li, J., Negro, A., Lopez, J., Bauman, A. L., Henson, E., et al., (2010) The mAKAPβ scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin. J. Mol. Cell. Cardiol. 48, 387-394.
60. Vargas, M. A., Tirnauer, J. S., Glidden, N., Kapiloff, M. S., and, Dodge-Kafka, K. L., (2012) Myocyte enhancer factor 2 (MEF2) tethering to muscle selective A-kinase anchoring protein (mAKAP) is necessary for myogenic differentiation. Cell. Signal. 24, 1496-1503.
61. Kritzer, M. D., Li, J., Passariello, C. L., Gayanilo, M., Thakur, H., et al., (2014) The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure. Circ. Heart Fail. 7, 663-672.
62. Passariello, C. L., Li, J., Dodge-Kafka, K., and, Kapiloff, M. S., (2015) mAKAP-a master scaffold for cardiac remodeling. J. Cardiovasc. Pharmacol. 65, 218-225.
63. Sapkota, G. P., Cummings, L., Newell, F. S., Armstrong, C., Bain, J., et al., (2007) BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem. J. 401, 29-38.
64. Amirak, E., Fuller, S. J., Sugden, P. H., and, Clerk, A., (2013) p90 ribosomal S6 kinases play a significant role in early gene regulation in the cardiomyocyte response to G(q)-protein-coupled receptor stimuli, endothelin-1 and α(1)-adrenergic receptor agonists. Biochem. J. 450, 351-363.
65. Zhang, Z., Liu, R., Townsend, P. A., and, Proud, C. G., (2013) p90(RSK)s mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes. J. Mol. Cell. Cardiol. 59, 139-147.
66. Nicol, R. L., Frey, N., Pearson, G., Cobb, M., Richardson, J., et al., (2001) Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20, 2757-2767.
67. Kehat, I., Davis, J., Tiburcy, M., Accornero, F., Saba-El-Leil, M. K., et al., (2011) Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ. Res. 108, 176-183.
68. Kimura, T. E., Jin, J., Zi, M., Prehar, S., Liu, W., et al., (2010) Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circ. Res. 106, 961-970.
69. Gelb, B. D., and, Tartaglia, M., (2011) RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it. J. Clin. Invest. 121, 844-847.
70. Ulm, S., Liu, W., Zi, M., Tsui, H., Chowdhury, S. K., et al., (2014) Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction. J. Mol. Cell. Cardiol. 72, 104-116.
71. Maloney, D. J., and, Hecht, S. M., (2005) Synthesis of a potent and selective inhibitor of p90 Rsk. Org. Lett. 7, 1097-1099.
72. Aronchik, I., Appleton, B. A., Basham, S. E., Crawford, K., Del Rosario, M., et al., (2014) Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancers. Mol. Cancer Res. 12, 803-812.
73. Cohen, M. S., Hadjivassiliou, H., and, Taunton, J., (2007) A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. Nat. Chem. Biol. 3, 156-160.
74. Ikuta, M., Kornienko, M., Byrne, N., Reid, J. C., Mizuarai, S., et al., (2007) Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: implications for the design of RSK1 specific inhibitors. Protein Sci. 16, 2626-2635.
75. Derewenda, U., Artamonov, M., Szukalska, G., Utepbergenov, D., Olekhnovich, N., et al., (2013) Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 A resolution. Acta Crystallogr. Sect. D: Biol. Crystallogr. 69, 266-275.
76. Moellering, R. E., Cornejo, M., Davis, T. N., Del Bianco, C., Aster, J. C., et al., (2009) Direct inhibition of the NOTCH transcription factor complex. Nature 462, 182-188.
77. Picaud, S., Wells, C., Felletar, I., Brotherton, D., Martin, S., et al., (2013) RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. Proc. Natl. Acad. Sci. USA 110, 19754-19759.
78. Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., et al., (2013) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19, 202-208.
79. Wang, S., Sun, W., Zhao, Y., McEachern, D., Meaux, I., et al., (2014) SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression. Cancer Res. 74, 5855-5865.